Anticoagulation

Nazli Okumus, Ashley Park, Eugene Yuridistky, et al

Read time: 29m 12s
AHA 25: TUXEDO-2: Ticagrelor vs Prasugrel in Diabetic PCI

Sripal Bangalore, Harriette Van Spall

Watch time: 17m 17s

Ton Duy Mai, Tri Huynh Quang Ho, Sy Van Hoang, et al

Read time: 19m 6s

Yugo Yamashita

The Parallax Podcast

Ankur Kalra

Monika Bhandari, Akshyaya Pradhan, Pravesh Vishwakarma, et al

Read time: 27m 35s

Elisabetta Bigagli, Jacopo Angelini, Alessandro Mugelli, et al

Read time: 18m 58s
EP 60: The Year 2021 in Review with Dr Sukh Nijjer – Part 1| recent cardiology trials

Sukhjinder Nijjer, Ankur Kalra,

Listen time: 59m 18s

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

Andreas Goette, Hein Heidbuchel

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)
Rivaroxaban vs Aspirin Post-AF Ablation: OCEAN Trial

Arrhythmia Academy

Media

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff

Watch time: 10m 36s

Broadcast

Anticoagulation
Prioritising Risk in CAD: A Patient-First Discussion

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Nicolas M Van Mieghem, Joost Daemen

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof

Watch time: 3m 42s

Yugo Yamashita

Marco Valgimigli, Eliano Navarese, Pascal Vranckx

Watch time: 1h 48m 18s (11 videos)

Broadcast

Anticoagulation

Guidelines & Statements
Clopidogrel or Ticagrelor: Why, When, for Whom?

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s

Media

AHA 25: The OCEAN Trial

Atul Verma

Watch time: 3m 46s
AF Symposium 25: LAAC Vs Oral Anticoagulation After Catheter Ablation

Walid Saliba

Watch time: 5m 35s
AHA 25: TUXEDO-2: Ticagrelor vs Prasugrel in Diabetic PCI

Sripal Bangalore, Harriette Van Spall

Watch time: 17m 17s

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Your Questions Answered: Revolutionising Thrombosis Treatment

Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain, et al

Watch time: 31m 49s

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Anticoagulation for AF: Considerations for Patients With Cancer

Husam Abdel-Qadir, Dan Lenihan, Joe Carver, et al

Watch time: 1h 4m 43s

Broadcast

Anticoagulation

Guidelines & Statements
What’s New in the European ACS Guidelines and How Will My Practice Change?

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 36s

Broadcast

Anticoagulation
Prioritising Risk in CAD: A Patient-First Discussion

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Broadcast

Anticoagulation

Guidelines & Statements
Clopidogrel or Ticagrelor: Why, When, for Whom?

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s

Broadcast

Anticoagulation

Guidelines & Statements
Edoxaban: ENGAGEing in Individualisation of DOACs

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Broadcast

Anticoagulation

Heart Failure
LAAC Summit Module 1: Reducing stroke risk & bleed in AF patients

A John Camm, Martin Bergmann, Tim Betts, et al

Broadcast

Anticoagulation
NSTE-ACS: Results From Crowdsourcing Research

Juan Carlos Kaski, Deepak L Bhatt, Felicita Andreotti, et al

Watch time: 38m 18s

Broadcast

Anticoagulation

Electrophysiology & Arrhythmia
Improving Efficiency in Stroke Prevention

David Hildick-Smith, Tim Betts, A John Camm, et al

Watch time: 1h 32m 45s

Articles

Challenges in Oral Antiplatelet Therapy

Patrick Wong

,

Umair Shafique

,

Citation:

European Cardiology 2010;6(1):53–7

DOI:

https://doi.org/10.15420/ecr.2010.6.1.53
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 65
  • Downloads: Downloads 2

Challenges in Oral Antiplatelet Therapy

Franz-Josef Neumann

,

Citation:

European Cardiology 2010:6(1):50-2

DOI:

https://doi.org/10.15420/ecr.2010.6.1.50
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 33
  • Downloads: Downloads 3

Antiplatelet Therapy in Acute Coronary Syndromes

Sasha Koul

,

David Erlinge

,

Citation:

European Cardiology 2010,6(1):58–61

DOI:

https://doi.org/10.15420/ecr.2010.6.1.58
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 41
  • Downloads: Downloads 5

Antiplatelet Resistance-Fact or Myth?

Paul A Gurbel

,

Udaya S Tantry

,

DOI:

https://doi.org/10.15420/ahhj.2009.7.1.50
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 123
  • Downloads: Downloads 7
  • Citations: 1
  • Read time: 15m